Very Long-term (15 Years) Results of Tricuspid Valve Repair. - Trial NCT05836493
Access comprehensive clinical trial information for NCT05836493 through Pure Global AI's free database. This phase not specified trial is sponsored by Michele De Bonis and is currently Completed. The study focuses on Tricuspid Regurgitation. Target enrollment is 146 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Michele De Bonis
Ospedale San Raffaele
Timeline & Enrollment
N/A
Oct 07, 2020
Oct 23, 2020
Primary Outcome
Mortality
Summary
Interest in Tricuspid valve disease grew exponentially in the last years in response to an
 increased awareness of the poor outcome of patients with functional Tricuspid Regurgitation
 (TR). Earlier reports advocated for a more conservative TR management in patients undergoing
 left-sided heart valve surgery but more recent guidelines advised for a more aggressive TR
 management, as accumulating evidence demonstrates its adverse impact on long term morbidity
 and mortality. Several papers have been published analyzing the results of surgical tricuspid
 valve repair but the length of the follow-up is usually limited to 10 to 12 years. With this
 study the investigators aim to analyze the very long-term results (15years) of tricuspid
 valve repair according to the surgical method employed for valve repair (suture vs ring
 annuloplasty).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05836493
Non-Device Trial